XFOR X4 Pharmaceuticals | $1.01 +3.5% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 5/31/2024 |
RARE Ultragenyx Pharmaceutical | $40.14 +3.9% | 5/31/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 -> $115.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/31/2024 |
MRVL Marvell Technology | $68.81 -10.5% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 5/31/2024 |
ZS Zscaler | $169.96 +8.5% | 5/31/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 5/31/2024 |
NET Cloudflare | $67.69 -0.4% | 5/31/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $80.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/31/2024 |
RBRK Rubrik | $30.48 +0.7% | 5/31/2024 | Initiated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 5/31/2024 |
|
BHVN Biohaven | $35.10 -0.4% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 5/30/2024 |
IMVT Immunovant | $25.39 -3.9% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 5/30/2024 |
SSYS Stratasys | $8.66 -4.0% | 5/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $23.00 -> $23.00 | Low | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 5/30/2024 |
CDXS Codexis | $3.38 -0.6% | 5/30/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Codexis (NASDAQ:CDXS) on 5/30/2024 |
ADCT ADC Therapeutics | $3.43 -0.3% | 5/30/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of ADC Therapeutics (NYSE:ADCT) on 5/30/2024 |
ALXO ALX Oncology | $10.63 -0.2% | 5/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 5/29/2024 |
NNOX Nano-X Imaging | $8.36 -3.0% | 5/29/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $18.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 5/29/2024 |
BBIO BridgeBio Pharma | $28.01 -2.9% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 5/28/2024 |
LUNR Intuitive Machines | $5.01 -0.6% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/28/2024 |
RDW Redwire | $5.14 +1.0% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $6.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 5/28/2024 |
RKLB Rocket Lab USA | $4.37 +0.9% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 5/28/2024 |
ORIC ORIC Pharmaceuticals | $8.99 +0.7% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/28/2024 |
TSHA Taysha Gene Therapies | $3.43 +9.6% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/28/2024 |
IRON Disc Medicine | $33.95 -2.0% | 5/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 -> $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 5/28/2024 |
ALKS Alkermes | $23.40 +0.8% | 5/23/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 -> $48.00 | Low | View details for Cantor Fitzgerald rating of Alkermes (NASDAQ:ALKS) on 5/23/2024 |
NVDA NVIDIA | $1,096.33 -0.8% | 5/23/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $1,200.00 -> $1,400.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 5/23/2024 |
SKYE Skye Bioscience | $11.61 -0.3% | 5/23/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 5/23/2024 |
SKYE Skye Bioscience | $11.61 -0.3% | 5/23/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $21.00 | Low | View details for Cantor Fitzgerald rating of Skye Bioscience (NASDAQ:SKYE) on 5/23/2024 |
OUST Ouster | $11.70 -3.8% | 5/22/2024 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $8.00 -> $13.00 | Low | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 5/22/2024 |
RBT Rubicon Technologies | $0.22 +1.6% | 5/21/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $1.60 -> $0.60 | Low | View details for Cantor Fitzgerald rating of Rubicon Technologies (NYSE:RBT) on 5/21/2024 |
ZLDPF Zealand Pharma A/S | $92.98 +4.0% | 5/21/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | | Low | View details for Cantor Fitzgerald rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 5/21/2024 |
UBSFY Ubisoft Entertainment | $4.82 +1.5% | 5/20/2024 | Upgraded by | Cantor Fitzgerald | Analyst E. James | Neutral -> Overweight | | Low | View details for Cantor Fitzgerald rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 5/20/2024 |
FULC Fulcrum Therapeutics | $7.85 +2.6% | 5/20/2024 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Fulcrum Therapeutics (NASDAQ:FULC) on 5/20/2024 |
ETNB 89bio | $7.90 +1.5% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 5/17/2024 |
AMAT Applied Materials | $215.08 -0.7% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 5/17/2024 |
DESP Despegar.com | $15.10 +0.1% | 5/17/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 5/17/2024 |
ABBV AbbVie | $161.24 +3.2% | 5/17/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | $200.00 | Low | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 5/17/2024 |
PGNY Progyny | $26.95 +1.2% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 5/16/2024 |
MREO Mereo BioPharma Group | $3.45 -3.9% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 5/16/2024 |
VNRX VolitionRx | $0.71 +3.6% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 5/16/2024 |
ABEO Abeona Therapeutics | $4.38 +4.0% | 5/16/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/16/2024 |
BLTE Belite Bio | $48.95 +0.4% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 5/15/2024 |
LUCD Lucid Diagnostics | $0.89 -1.8% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 5/15/2024 |
ASND Ascendis Pharma A/S | $135.10 -1.7% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/15/2024 |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8007&Placement=NativeDisplay&Source=NativeDisplay) You must read this new presentation from Porter Stansberry. |
SMTI Sanara MedTech | $29.70 -1.6% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 5/15/2024 |
PGEN Precigen | $1.40 +5.3% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Precigen (NASDAQ:PGEN) on 5/15/2024 |
SSTI SoundThinking | $16.07 +0.5% | 5/15/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 5/15/2024 |
TSHA Taysha Gene Therapies | $3.43 +9.6% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/15/2024 |
IRON Disc Medicine | $33.95 -2.0% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 5/15/2024 |
LUNR Intuitive Machines | $5.01 -0.6% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/15/2024 |
CRIS Curis | $10.36 -2.5% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Curis (NASDAQ:CRIS) on 5/15/2024 |
ADI Analog Devices | $234.49 +2.0% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 -> $240.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 5/15/2024 |
NXPI NXP Semiconductors | $272.10 +0.2% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 -> $325.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 5/15/2024 |
TXN Texas Instruments | $195.01 -0.3% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 -> $210.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 5/15/2024 |
HL Hecla Mining | $5.89 +0.7% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Hecla Mining (NYSE:HL) on 5/9/2024 |
XGN Exagen | $1.95 +1.6% | 5/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 5/14/2024 |
DDD 3D Systems | $3.52 -1.9% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $8.25 | Low | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 5/14/2024 |
CAPR Capricor Therapeutics | $5.68 +2.3% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2024 |
ATOS Atossa Therapeutics | $1.30
| 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 5/14/2024 |
RCEL AVITA Medical | $9.61 +3.3% | 5/14/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 5/14/2024 |
CRNX Crinetics Pharmaceuticals | $44.41 -2.1% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/14/2024 |
ADMA ADMA Biologics | $9.55 +0.7% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 5/10/2024 |
ELUT Elutia | $3.25 +0.9% | 5/10/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 5/10/2024 |
RDW Redwire | $5.14 +1.0% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 5/10/2024 |
PDSB PDS Biotechnology | $2.98 +1.0% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 5/9/2024 |
PCVX Vaxcyte | $70.27 +0.1% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 5/9/2024 |
PWSC PowerSchool | $21.44 +1.2% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of PowerSchool (NYSE:PWSC) on 5/9/2024 |
INVZ Innoviz Technologies | $1.05 -5.4% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 5/9/2024 |
JANX Janux Therapeutics | $53.50 +6.1% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 5/9/2024 |
MIRM Mirum Pharmaceuticals | $24.03 -1.7% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $40.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/9/2024 |
ALEC Alector | $4.92
| 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 5/9/2024 |
MKFG Markforged | $0.42 -3.1% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $1.45 -> $1.30 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 5/9/2024 |
KVYO Klaviyo | $22.64 -0.4% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 5/9/2024 |
MNKD MannKind | $4.67 +3.8% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 5/9/2024 |
LFMD LifeMD | $8.25 -2.9% | 5/9/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 5/9/2024 |
CRSP CRISPR Therapeutics | $53.74 -0.6% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/9/2024 |
DCGO DocGo | $2.93 -0.7% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 5/9/2024 |
NPCE NeuroPace | $6.91 +5.7% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 5/9/2024 |
ACAD ACADIA Pharmaceuticals | $15.10 +0.7% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/9/2024 |
CATX Perspective Therapeutics | $1.38 +4.5% | 5/9/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 5/9/2024 |
EVGO EVgo | $2.03 -2.4% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $5.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 5/9/2024 |
RIVN Rivian Automotive | $10.92 -0.5% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 5/8/2024 |
SHLS Shoals Technologies Group | $7.87 -3.7% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/8/2024 |
JNJ Johnson & Johnson | $146.67 +1.0% | 5/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 5/6/2024 |
GPCR Structure Therapeutics | $34.20 +1.3% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 5/3/2024 |
CYBR CyberArk Software | $229.25 +1.6% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 5/3/2024 |
REGN Regeneron Pharmaceuticals | $980.16 +1.1% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/3/2024 |
UDMY Udemy | $8.84 -0.1% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 5/3/2024 |
LBPH Longboard Pharmaceuticals | $18.87 +5.4% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/3/2024 |
ASND Ascendis Pharma A/S | $135.10 -1.7% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/3/2024 |
NET Cloudflare | $67.69 -0.4% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/3/2024 |
FTNT Fortinet | $59.32 +2.3% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 5/3/2024 |
CI The Cigna Group | $344.62 +4.1% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
RARE Ultragenyx Pharmaceutical | $40.14 +3.9% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/3/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8085&Placement=NativeDisplay&Source=NativeDisplay) Click here for the full story… |
CERS Cerus | $1.79 -2.2% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 5/3/2024 |
SPT Sprout Social | $32.65 +0.4% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 -> $46.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
CGON CG Oncology | $32.58 -5.0% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 5/2/2024 |
FRSH Freshworks | $12.88 -2.1% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $19.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
CSGS CSG Systems International | $43.15 +0.7% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $63.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 5/2/2024 |
QCOM QUALCOMM | $204.05 -0.4% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 5/2/2024 |
SRPT Sarepta Therapeutics | $129.86 +4.3% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2024 |
TSLA Tesla | $178.08 -0.4% | 5/2/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $230.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 5/2/2024 |
CVS CVS Health | $59.60 +6.4% | 5/1/2024 | Downgraded by | Cantor Fitzgerald | Analyst S. James | Overweight -> Neutral | $87.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 5/1/2024 |
AMD Advanced Micro Devices | $166.90 +0.1% | 5/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 5/1/2024 |
FUBO fuboTV | $1.25
| 5/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.90 | Low | View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 5/1/2024 |
LLY Eli Lilly and Company | $820.34 +0.6% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/30/2024 |
NXPI NXP Semiconductors | $272.10 +0.2% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/30/2024 |
ATNM Actinium Pharmaceuticals | $8.15 +0.5% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/30/2024 |
CMPS COMPASS Pathways | $7.38 -0.5% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/30/2024 |
COUR Coursera | $7.60 -0.1% | 4/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/30/2024 |
ACAD ACADIA Pharmaceuticals | $15.10 +0.7% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/30/2024 |
TSHA Taysha Gene Therapies | $3.43 +9.6% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/30/2024 |
CMCL Caledonia Mining | $10.45 -1.7% | 4/29/2024 | Upgraded by | Cantor Fitzgerald | - | Hold -> Speculative Buy | $13.50 | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 4/29/2024 |
BMRN BioMarin Pharmaceutical | $75.07 +0.8% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $358.12 +3.1% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $10.62 -5.0% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $932.44 -1.9% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $140.94 -0.2% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $91.15 -5.1% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
TXN Texas Instruments | $195.01 -0.3% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $67.24 +2.4% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $4.83 +2.1% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $93.24 -0.5% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
MTLS Materialise | $5.00 -1.2% | 4/24/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
ABEO Abeona Therapeutics | $4.38 +4.0% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $12.69 +2.2% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $57.79 +0.9% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $3.43 +9.6% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $135.10 -1.7% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $35.10 -0.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
GPCR Structure Therapeutics | $34.20 +1.3% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $125.54 +0.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $135.28 +1.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $7.38 -0.5% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $7.60 -0.1% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $313.67 -0.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $229.25 +1.6% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $110.18 -6.2% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $59.32 +2.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $67.69 -0.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $294.91 +0.6% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $169.96 +8.5% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $22.64 -0.4% | 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $980.16 +1.1% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8085&Placement=NativeDisplay&Source=NativeDisplay) Click here for the full story… |
LLY Eli Lilly and Company | $820.34 +0.6% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $146.67 +1.0% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $28.66 +1.6% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
VFS VinFast Auto | $4.89 +0.4% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $9.00 | Low | View details for Cantor Fitzgerald rating of VinFast Auto (NASDAQ:VFS) on 4/15/2024 |
ALXO ALX Oncology | $10.63 -0.2% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $0.78 +3.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $68.81 -10.5% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $29.40 +1.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $36.36 +1.5% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $5.05 +3.5% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
PRTA Prothena | $20.81 +3.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $35.10 -0.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $12.86 -1.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $27.60 +1.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $9.41 +1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $135.22 +1.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $189.80 +2.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $495.37 +2.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $2.47 +14.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $15.10 +0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $73.43 -1.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $105.25 -0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $18.87 +5.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.42 -2.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $135.41 -0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $38.07 -2.5% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $344.62 +4.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $59.60 +6.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $538.48 +6.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $339.75 +1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
HCAT Health Catalyst | $6.63 +1.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
HUM Humana | $358.12 +3.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $36.34 -3.2% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.63 -8.6% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $34.20 +1.3% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $272.10 +0.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $759.53 -1.4% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $932.44 -1.9% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $125.00 -1.0% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $204.05 -0.4% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $195.01 -0.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $75.29 -0.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $49.00 -0.5% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $215.08 -0.7% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $10.19 +2.6% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $40.14 +3.9% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $7.90 +1.5% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |
MRK Merck & Co., Inc. | $125.54 +0.8% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/5/2024 |
MOH Molina Healthcare | $314.58 +2.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 4/4/2024 |
UNH UnitedHealth Group | $495.37 +2.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/4/2024 |
Must-See: Elon’s New Invention is Absolutely Insane (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8085&Placement=NativeDisplay&Source=NativeDisplay) Click here for the full story… |
SPRO Spero Therapeutics | $1.42
| 4/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 4/4/2024 |
STOK Stoke Therapeutics | $14.62 +6.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 4/4/2024 |
ATAI Atai Life Sciences | $1.57 -6.5% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 4/4/2024 |
PRE Prenetics Global | $5.99 +1.4% | 4/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 4/4/2024 |
CNC Centene | $71.59 +3.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 4/4/2024 |
CVS CVS Health | $59.60 +6.4% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/4/2024 |
ELV Elevance Health | $538.48 +6.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/4/2024 |
HUM Humana | $358.12 +3.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/4/2024 |
TNGX Tango Therapeutics | $6.92 +3.9% | 4/4/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 4/4/2024 |
INTC Intel | $30.85 +2.2% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/3/2024 |
ANNX Annexon | $4.83 +2.1% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/3/2024 |
PRCH Porch Group | $2.10 +2.4% | 4/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $3.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 4/3/2024 |
RIVN Rivian Automotive | $10.92 -0.5% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 4/3/2024 |
LEGN Legend Biotech | $40.01 -7.7% | 4/3/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 4/3/2024 |
AFMD Affimed | $4.35 +7.1% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
CRVS Corvus Pharmaceuticals | $2.16 +2.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 4/1/2024 |
VINC Vincerx Pharma | $0.63 -8.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $8.15 +0.5% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
AWH Aspira Women's Health | $2.47 +14.9% | 4/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/1/2024 |
HUMA Humacyte | $7.48 -17.8% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 4/1/2024 |
ZVRA Zevra Therapeutics | $4.65 -0.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/1/2024 |
SCYX SCYNEXIS | $2.41 +2.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 4/1/2024 |
ASND Ascendis Pharma A/S | $135.10 -1.7% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/1/2024 |
LLY Eli Lilly and Company | $820.34 +0.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/1/2024 |
NVO Novo Nordisk A/S | $135.28 +1.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/1/2024 |
PFE Pfizer | $28.66 +1.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/1/2024 |
MIGI Mawson Infrastructure Group | $1.21 -6.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1.00 | Low | View details for Cantor Fitzgerald rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/1/2024 |
EVLV Evolv Technologies | $2.86 +3.6% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/28/2024 |
CMCL Caledonia Mining | $10.45 -1.7% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Speculative Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 3/28/2024 |
CLSK CleanSpark | $16.07 -2.0% | 3/28/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $20.00 | N/A | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 3/28/2024 |
BITF Bitfarms | $2.24 -0.4% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 3/28/2024 |
CIFR Cipher Mining | $3.71 -1.3% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/28/2024 |
IREN Iris Energy | $7.79 +5.1% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 3/28/2024 |
RIOT Riot Platforms | $9.74 -3.1% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/28/2024 |
WULF TeraWulf | $2.18 -4.4% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/28/2024 |
OUST Ouster | $11.70 -3.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/28/2024 |
MREO Mereo BioPharma Group | $3.45 -3.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/28/2024 |
HRMY Harmony Biosciences | $29.40 +1.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 3/28/2024 |
CXM Sprinklr | $11.21 -2.3% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ZS Zscaler | $169.96 +8.5% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/27/2024 |
MRK Merck & Co., Inc. | $125.54 +0.8% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2024 |
VNRX VolitionRx | $0.71 +3.6% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 3/27/2024 |
SMTI Sanara MedTech | $29.70 -1.6% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 -> $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/27/2024 |
LUCD Lucid Diagnostics | $0.89 -1.8% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.80 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/27/2024 |
LUNR Intuitive Machines | $5.01 -0.6% | 3/22/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $105.25 -0.2% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
CLDX Celldex Therapeutics | $33.30 -1.0% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 3/22/2024 |
CABA Cabaletta Bio | $10.19 +2.6% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
DESP Despegar.com | $15.10 +0.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/22/2024 |
MREO Mereo BioPharma Group | $3.45 -3.9% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/22/2024 |
CPRX Catalyst Pharmaceuticals | $16.17 +0.4% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/22/2024 |
SOUN SoundHound AI | $5.05 +3.5% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Underweight | $5.80 -> $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/20/2024 |
NVO Novo Nordisk A/S | $135.28 +1.9% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 3/20/2024 |
TSHA Taysha Gene Therapies | $3.43 +9.6% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/20/2024 |
WULF TeraWulf | $2.18 -4.4% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/20/2024 |
JANX Janux Therapeutics | $53.50 +6.1% | 3/20/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 3/20/2024 |
BBIO BridgeBio Pharma | $28.01 -2.9% | 3/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/19/2024 |
SHLS Shoals Technologies Group | $7.87 -3.7% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $18.87 +5.4% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $9.50 -1.0% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |